Schweiger Dermatology Group, Pllc - Morristown

CLIA Laboratory Citation Details

2
Total Citations
14
Total Deficiencyies
6
Unique D-Tags
CMS Certification Number 31D2154902
Address 290 Madison Avenue, Building 5, Suite 9, Morristown, NJ, 07960
City Morristown
State NJ
Zip Code07960
Phone(973) 571-2121

Citation History (2 surveys)

Survey - December 7, 2021

Survey Type: Standard

Survey Event ID: UVNG11

Deficiency Tags: D5217 D6102 D5217 D6102

Summary:

Summary Statement of Deficiencies D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on surveyor review of the Biannual Assessment (BA) records and interview with the Office Manager (OM), the laboratory failed to verify the accuracy of Histopathology testing twice annually in the calendar year 2021. The OM confirmed on 12/9/21 at 12:15 pm that the laboratory did not perform BA for Histopathology testing twice in 2021. D6102 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(12) The laboratory director must ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: Based on surveyor review of Personnel Records (PR) and interview with the Office Manager (OM), the Laboratory Director failed to ensure that the education records were available for all Testing Personnel (TP) on the date of the survey. The finding includes: 1. Education records were not available for one out of one TP. 2. The OM confirmed on 12/7/21 at 12:00 pm that education records were not available. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 20, 2019

Survey Type: Standard

Survey Event ID: IDV911

Deficiency Tags: D5291 D5403 D5403 D5417 D6102 D5291 D5417 D6102 D6103 D6103

Summary:

Summary Statement of Deficiencies D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on surveyor review of the Procedure Manual and interview with the Office Manger (OM), the laboratory failed to establish a written procedure for Biannual Assessment (BA) from March 2019 to the date of survey. The OM confirmed on 6/20 /19 at 11:50 am that a BA procedure was not established. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access